Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nitrosoureas in central nervous system tumors.

× No keyword cloud information.

12 in total

Review 1. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

2. Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.

Authors: E Zander; N de Tribolet; L Wagenknecht
Journal: Acta Neurochir (Wien) Date: 1978 Impact factor: 2.216

3. Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor.

Authors: M Nagarkatti; P S Nagarkatti; A M Kaplan
Journal: Cancer Immunol Immunother Date: 1988 Impact factor: 6.968

4. Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.

Authors: A P Bowles; C G Pantazis; W Wansley; M B Allen
Journal: J Neurooncol Date: 1990-04 Impact factor: 4.130

5. Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.

Authors: L C Panasci; M Dufour; L Chevalier; G Isabel; P Lazarus; A McQuillan; E Arbit; S Brem; W Feindel
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

6. CCNU-adriamycin association induces earlier and more severe nephropathy in rats.

Authors: G Raguenez-Viotte; M Lahoue; T Ducastelle; J P Morin; J P Fillastre
Journal: Arch Toxicol Date: 1988 Impact factor: 5.153

7. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.

Authors: P Paoletti; G Robustelli della Cuna; R Knerich; M R Strada
Journal: Acta Neurochir (Wien) Date: 1978 Impact factor: 2.216

8. Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.

Authors: A Malapetsa; J L Bramson; A J Noë; L C Panasci
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

9. Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Authors: R I Fisher; G L Mandell; F Bostick; M G McMenamin; T Anderson
Journal: Clin Exp Immunol Date: 1980-02 Impact factor: 4.330

10. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.

Authors: R Osieka; P Glatte; R Pannenbäcker; C G Schmidt
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333